nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A conservative viewpoint on linkage in Alzheimer's disease
|
Roses, Allen D. |
|
1989 |
10 |
5 |
p. 427-429 3 p. |
artikel |
2 |
Additional arrows for the β-amyloid target
|
Cordell, Barbara |
|
1989 |
10 |
5 |
p. 468-470 3 p. |
artikel |
3 |
A different view of A68 and amyloid
|
Davies, Peter |
|
1989 |
10 |
5 |
p. 408-409 2 p. |
artikel |
4 |
A functional framework for neurotrophic activities
|
Haverkamp, Lanny J. |
|
1989 |
10 |
5 |
p. 537-539 3 p. |
artikel |
5 |
Age page
|
|
|
1989 |
10 |
5 |
p. 652-654 3 p. |
artikel |
6 |
Alzheimer's amyloid: Is it possible it's not rotten to the core?
|
Bartus, Raymond T. |
|
1989 |
10 |
5 |
p. 479- 1 p. |
artikel |
7 |
Alzheimer's disease is a degenerative disorder
|
Katzman, Robert |
|
1989 |
10 |
5 |
p. 581-582 2 p. |
artikel |
8 |
Amyloid and Alzheimer's disease: A question of specificity
|
Perry, Elaine K. |
|
1989 |
10 |
5 |
p. 473-474 2 p. |
artikel |
9 |
Amyloid and Alzheimer's disease—Cause or effect?
|
Yankner, Bruce A. |
|
1989 |
10 |
5 |
p. 470-471 2 p. |
artikel |
10 |
Amyloid plaques, neurofibrillary tangles and their relevance for the study of Alzheimer's disease
|
Goedert, M. |
|
1989 |
10 |
5 |
p. 405-406 2 p. |
artikel |
11 |
A new orientation to an old problem: It's simply a matter of time
|
Bartus, Raymond T. |
|
1989 |
10 |
5 |
p. 449- 1 p. |
artikel |
12 |
Antiamyloid therapy—a distant horizon
|
Shelanski, Michael L. |
|
1989 |
10 |
5 |
p. 476-477 2 p. |
artikel |
13 |
Author index
|
|
|
1989 |
10 |
5 |
p. 659- 1 p. |
artikel |
14 |
Author's response to commentaries
|
Selkoe, Dennis J. |
|
1989 |
10 |
5 |
p. 412-414 3 p. |
artikel |
15 |
Authors' response to commentaries
|
Hefti, F. |
|
1989 |
10 |
5 |
p. 552-553 2 p. |
artikel |
16 |
Authors' response to commentaries
|
Snow, Alan D. |
|
1989 |
10 |
5 |
p. 510-512 3 p. |
artikel |
17 |
Authors' response to commentaries
|
Caputo, Claudia B. |
|
1989 |
10 |
5 |
p. 477-478 2 p. |
artikel |
18 |
Authors' response to commentaries
|
St George-Hyslop, P.H. |
|
1989 |
10 |
5 |
p. 446-448 3 p. |
artikel |
19 |
Authors' response to commentaries
|
Greenamyre, J.Timothy |
|
1989 |
10 |
5 |
p. 618-620 3 p. |
artikel |
20 |
Authors' response to commentaries
|
Butcher, Larry L. |
|
1989 |
10 |
5 |
p. 588-590 3 p. |
artikel |
21 |
Author's response to commentaries
|
Harbaugh, Robert E. |
|
1989 |
10 |
5 |
p. 648-650 3 p. |
artikel |
22 |
Beta-amyloid deposition and paired helical filament formation: Which histopathological feature is more significant in Alzheimer's disease?
|
Dickson, Dennis W. |
|
1989 |
10 |
5 |
p. 402-404 3 p. |
artikel |
23 |
Calendar
|
|
|
1989 |
10 |
5 |
p. 655-657 3 p. |
artikel |
24 |
Causes of cell damage in hypoxia/ischemia, aging and Alzheimer's disease
|
Gibson, Gary |
|
1989 |
10 |
5 |
p. 608-609 2 p. |
artikel |
25 |
Cerebral amyloidosis, ageing and Alzheimer's disease; A contribution from studies on Down's syndrome
|
Mann, David M.A. |
|
1989 |
10 |
5 |
p. 397-399 3 p. |
artikel |
26 |
Combining CNS transplantation and gene transfer
|
Breakefield, Xandra O. |
|
1989 |
10 |
5 |
p. 647-648 2 p. |
artikel |
27 |
Considerations in the treatment of neurological disorders with trophic factors
|
Morgan, David G. |
|
1989 |
10 |
5 |
p. 547-549 3 p. |
artikel |
28 |
Cytoskeletal protein pathology and the formation of beta-amyloid fibers in Alzheimer's disease
|
Wisniewski, Henry M. |
|
1989 |
10 |
5 |
p. 409-412 4 p. |
artikel |
29 |
Cytoskeleton and NGF in the pathogenesis and treatment of Alzheimer's disease
|
Shelanski, Michael L. |
|
1989 |
10 |
5 |
p. 577- 1 p. |
artikel |
30 |
Delivery of neuroactive compounds to the brain: Potential utility of genetically modified cells
|
Tuszynski, Mark H. |
|
1989 |
10 |
5 |
p. 644-645 2 p. |
artikel |
31 |
Designer genes: Current fad or lasting fashion?
|
Bartus, Raymond T. |
|
1989 |
10 |
5 |
p. 415- 1 p. |
artikel |
32 |
Detrimental actions of neurotrophic agents
|
Hefti, Franz |
|
1989 |
10 |
5 |
p. 583- 1 p. |
artikel |
33 |
Direct comparisons of CNS directed therapies are needed
|
Gash, Don M. |
|
1989 |
10 |
5 |
p. 645-646 2 p. |
artikel |
34 |
Drug delivery to the brain: The problem lurking behind the problem?
|
Bartus, Raymond T. |
|
1989 |
10 |
5 |
p. 621- 1 p. |
artikel |
35 |
Epidermal growth factor receptor ≠ nerve growth factor
|
Williams, Lawrence R. |
|
1989 |
10 |
5 |
p. 586-587 2 p. |
artikel |
36 |
Evidence for etiologic heterogeneity in Alzheimer's disease
|
Bird, Thomas D. |
|
1989 |
10 |
5 |
p. 432-434 3 p. |
artikel |
37 |
Excitatory amino acids and Alzheimer's disease
|
Greenamyre, J.Timothy |
|
1989 |
10 |
5 |
p. 593-602 10 p. |
artikel |
38 |
Excitatory amino acids and Alzheimer's disease: Idle thoughts on an exciting subject
|
McGeer, Edith G. |
|
1989 |
10 |
5 |
p. 614-616 3 p. |
artikel |
39 |
Familial Alzheimer's disease: Genetic analysis related to disease heterogeneity, Down syndrome and human brain evolution
|
Schapiro, Mark B. |
|
1989 |
10 |
5 |
p. 435-436 2 p. |
artikel |
40 |
Familial Alzheimer's disease: Progress and problems
|
St George-Hyslop, Peter H. |
|
1989 |
10 |
5 |
p. 417-425 9 p. |
artikel |
41 |
Focusing on IL1-promotion of β-amyloid precursor protein synthesis as an early event in Alzheimer's disease
|
Blume, Arthur J. |
|
1989 |
10 |
5 |
p. 406-408 3 p. |
artikel |
42 |
Function of neurotrophic factors in the adult and aging brain and their possible use in the treatment of neurodegenerative diseases
|
Hefti, F. |
|
1989 |
10 |
5 |
p. 515-533 19 p. |
artikel |
43 |
Genetics and Alzheimer's disease: Notes of an environment watcher (with apologies to L. Thomas)
|
Perl, Daniel P. |
|
1989 |
10 |
5 |
p. 444-446 3 p. |
artikel |
44 |
Genetics and the diagnosis of Alzheimer's disease: True signals and original din
|
Heston, Leonard L. |
|
1989 |
10 |
5 |
p. 443-444 2 p. |
artikel |
45 |
Genetic studies of typical Alzheimer's disease
|
Mohs, Richard C. |
|
1989 |
10 |
5 |
p. 438-439 2 p. |
artikel |
46 |
Genetic studies support a neuronal origin for the beta amyloid polypeptide
|
Neve, Rachael L. |
|
1989 |
10 |
5 |
p. 400-402 3 p. |
artikel |
47 |
Heterogeneity in Alzheimer's disease
|
Folstein, Marshal F. |
|
1989 |
10 |
5 |
p. 434-435 2 p. |
artikel |
48 |
How well do we understand neurotrophic factors and the control of CNS neuronal growth?
|
Walicke, Patricia Ann |
|
1989 |
10 |
5 |
p. 535-537 3 p. |
artikel |
49 |
Increasing amyloid peptide precursor production and its impact on Alzheimer's disease
|
Vitek, Michael P. |
|
1989 |
10 |
5 |
p. 471-473 3 p. |
artikel |
50 |
Information related to research funding, grants and awards
|
|
|
1989 |
10 |
5 |
p. 651- 1 p. |
artikel |
51 |
Methodological considerations in cognitive disorders or: “The baby needs enough bath water”
|
Read, Stephen |
|
1989 |
10 |
5 |
p. 634-635 2 p. |
artikel |
52 |
Modelling the occurrence and pathology of Alzheimer's disease
|
Hardy, J.A. |
|
1989 |
10 |
5 |
p. 429-431 3 p. |
artikel |
53 |
Molecular genetic analysis of early onset familial Alzheimer's disease
|
Van Broeckhoven, Christine L. |
|
1989 |
10 |
5 |
p. 437-438 2 p. |
artikel |
54 |
Molecular pathology of amyloidogenic proteins and the role of vascular amyloidosis in Alzheimer's disease
|
Selkoe, Dennis J. |
|
1989 |
10 |
5 |
p. 387-395 9 p. |
artikel |
55 |
Nerve growth factor in Alzheimer's disease: To treat or not to treat?
|
Mobley, William C. |
|
1989 |
10 |
5 |
p. 578-580 3 p. |
artikel |
56 |
Neurite outgrowth and the amyloid protein precursor
|
Hammond, David N. |
|
1989 |
10 |
5 |
p. 575-576 2 p. |
artikel |
57 |
Neurotrophic agents may exacerbate the pathologic cascade of Alzheimer's disease
|
Butcher, Larry L. |
|
1989 |
10 |
5 |
p. 557-570 14 p. |
artikel |
58 |
Neurotrophic factors and Alzheimer's disease
|
Wainer, Bruce H. |
|
1989 |
10 |
5 |
p. 540-542 3 p. |
artikel |
59 |
Neurotrophic factors: Can the degenerating brain be induced to heal itself?
|
Bartus, Raymond T. |
|
1989 |
10 |
5 |
p. 513- 1 p. |
artikel |
60 |
Neurotrophic factors: The good, the bad or the ugly?
|
Bartus, Raymond T. |
|
1989 |
10 |
5 |
p. 555- 1 p. |
artikel |
61 |
New directions in CNS drug delivery
|
Langer, Robert |
|
1989 |
10 |
5 |
p. 642-644 3 p. |
artikel |
62 |
NGF and Alzheimer's disease—Considerations and caveats
|
Yankner, Bruce A. |
|
1989 |
10 |
5 |
p. 546-547 2 p. |
artikel |
63 |
NGF and Alzheimer's disease: Unfulfilled promise and untapped potential
|
Kordower, Jeffrey H. |
|
1989 |
10 |
5 |
p. 543-544 2 p. |
artikel |
64 |
N-methyl-D-aspartate receptors and Alzheimer's disease
|
Cotman, C.W. |
|
1989 |
10 |
5 |
p. 603-605 3 p. |
artikel |
65 |
Noninvasive drug delivery to the brain
|
Brewster, Marcus E. |
|
1989 |
10 |
5 |
p. 638-639 2 p. |
artikel |
66 |
Non-NMDA receptor-mediated neuronal injury in Alzheimer's disease?
|
Choi, Dennis W. |
|
1989 |
10 |
5 |
p. 605-606 2 p. |
artikel |
67 |
Novel CNS-directed drug delivery systems in Alzheimer's disease and other neurological disorders
|
Harbaugh, Robert E. |
|
1989 |
10 |
5 |
p. 623-629 7 p. |
artikel |
68 |
Novel drug delivery systems: Opportunities and caveats
|
Drachman, David A. |
|
1989 |
10 |
5 |
p. 632-633 2 p. |
artikel |
69 |
Novel therapy for Alzheimer's disease
|
DeFeudis, F.V. |
|
1989 |
10 |
5 |
p. 467-468 2 p. |
artikel |
70 |
Plasticity, pathology, and Alzheimer's disease
|
Geddes, J.W. |
|
1989 |
10 |
5 |
p. 571-573 3 p. |
artikel |
71 |
Potential roles of protease inhibitors in Alzheimer's disease
|
Abraham, Carmela R. |
|
1989 |
10 |
5 |
p. 463-465 3 p. |
artikel |
72 |
Preface
|
Bartus, Raymond T. |
|
1989 |
10 |
5 |
p. 381- 1 p. |
artikel |
73 |
Properties of nervous tissue proteoglycans relevant to studies on Alzheimer's disease
|
Margolis, Richard U. |
|
1989 |
10 |
5 |
p. 500-502 3 p. |
artikel |
74 |
Proteoglycans in amyloidogenesis
|
Shirahama, Tsuranobu |
|
1989 |
10 |
5 |
p. 508-510 3 p. |
artikel |
75 |
Proteoglycans in the pathogenesis of Alzheimer's disease and other amyloidoses
|
Snow, Alan D. |
|
1989 |
10 |
5 |
p. 481-497 17 p. |
artikel |
76 |
Proteoglycans in the pathogenesis of amyloidosis
|
Linker, Alfred |
|
1989 |
10 |
5 |
p. 507-508 2 p. |
artikel |
77 |
Pyramidal neuron loss and “glycine-site therapy”: A need for an animal model and study in late-life depression
|
Bowen, David M. |
|
1989 |
10 |
5 |
p. 616-618 3 p. |
artikel |
78 |
Role of neurotrophic factors in Alzheimer's disease
|
Chen, Karen S. |
|
1989 |
10 |
5 |
p. 545-546 2 p. |
artikel |
79 |
Selective neuronal vulnerability and the distribution of N-methyl-D-aspartate (NMDA) receptors
|
Lee, Kevin S. |
|
1989 |
10 |
5 |
p. 609-611 3 p. |
artikel |
80 |
Selectivity of excitotoxic mechanisms in Alzheimer's disease
|
May, Patrick C. |
|
1989 |
10 |
5 |
p. 606-608 3 p. |
artikel |
81 |
Site-specific drug delivery to CNS: Old and new
|
Hollister, Leo E. |
|
1989 |
10 |
5 |
p. 631- 1 p. |
artikel |
82 |
Strategies for drug delivery through the blood-brain barrier
|
Pardridge, William M. |
|
1989 |
10 |
5 |
p. 636-637 2 p. |
artikel |
83 |
Sustained and controlled release of neuroactive substances in the CNS by encapsulation into implantable polymers
|
Peterson, Gary M. |
|
1989 |
10 |
5 |
p. 639-640 2 p. |
artikel |
84 |
The amyloid proteins of Alzheimer's disease as potential targets for drug therapy
|
Caputo, Claudia B. |
|
1989 |
10 |
5 |
p. 451-461 11 p. |
artikel |
85 |
The biological roles of heparan sulfate proteoglycans in the nervous system
|
Schubert, David |
|
1989 |
10 |
5 |
p. 504-506 3 p. |
artikel |
86 |
The etiology of Alzheimer's disease: An epidemiologic point of view
|
Rocca, Walter A. |
|
1989 |
10 |
5 |
p. 440-441 2 p. |
artikel |
87 |
The genetics of Alzheimer's disease—Where does it lead?
|
Whatley, Stephen A. |
|
1989 |
10 |
5 |
p. 441-443 3 p. |
artikel |
88 |
The impending Alzheimer's crisis: Can we be saved by the revolution?
|
Bartus, Raymond T. |
|
1989 |
10 |
5 |
p. 383-384 2 p. |
artikel |
89 |
Theme and variations on a string of amyloid
|
Kisilevsky, Robert |
|
1989 |
10 |
5 |
p. 499-500 2 p. |
artikel |
90 |
The necessity of human trials of putative therapies for Alzheimer's disease
|
Knopman, David |
|
1989 |
10 |
5 |
p. 633-634 2 p. |
artikel |
91 |
The role of neuronal energy in the neurotoxicity of excitatory amino acids
|
Henneberry, Richard C. |
|
1989 |
10 |
5 |
p. 611-613 3 p. |
artikel |
92 |
The study of Alzheimer's pathology: The long and winding road
|
Bartus, Raymond T. |
|
1989 |
10 |
5 |
p. 385-386 2 p. |
artikel |
93 |
The ultimate Shakespearean tragedy: Are selective areas of the brain committing suicide?
|
Bartus, Raymond T. |
|
1989 |
10 |
5 |
p. 591- 1 p. |
artikel |
94 |
The use of hollow polymer fibers for the delivery of bioactive molecules to the brain
|
Springer, Joe E. |
|
1989 |
10 |
5 |
p. 640-641 2 p. |
artikel |
95 |
Toward a therapeutic strategy based on amyloid precursor protein: Unanswered questions
|
Davis, Kenneth L. |
|
1989 |
10 |
5 |
p. 475-476 2 p. |
artikel |
96 |
Towards trophic factor pharmacology?
|
Cuello, A.Claudio |
|
1989 |
10 |
5 |
p. 539-540 2 p. |
artikel |
97 |
Trophic factors and Alzheimer's disease
|
Phelps, Creighton H. |
|
1989 |
10 |
5 |
p. 584-586 3 p. |
artikel |
98 |
Venn diagrams and neuronal vulnerability
|
Sapolsky, Robert M. |
|
1989 |
10 |
5 |
p. 613-614 2 p. |
artikel |
99 |
What is the significance of the binding of proteoglycans to amyloid?
|
Caputo, Claudia B. |
|
1989 |
10 |
5 |
p. 503-504 2 p. |
artikel |
100 |
What mediates between β-amyloid and paired helical filaments?
|
Ihara, Yasuo |
|
1989 |
10 |
5 |
p. 573-574 2 p. |
artikel |
101 |
What role(s) may extracellular matrix, particularly heparan sulfate, play in amyloid of Alzheimer's disease
|
Benditt, Earl P. |
|
1989 |
10 |
5 |
p. 506- 1 p. |
artikel |
102 |
Why do neurons die when deprived of trophic factor?
|
Johnson Jr., Eugene M. |
|
1989 |
10 |
5 |
p. 549-552 4 p. |
artikel |
103 |
Will neurotrophic agents be harmful in Alzheimer's disease?
|
Appel, Stanley H. |
|
1989 |
10 |
5 |
p. 580-581 2 p. |
artikel |
104 |
Zeroing in on amyloid proteins in Alzheimer disease therapy
|
Festoff, Barry W. |
|
1989 |
10 |
5 |
p. 465-466 2 p. |
artikel |